atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility Study Data

The loan is in addition to atais previously announced initial equity investment of an approximately 25% interest in IntelGenx.